BE809369A - Composes triaziniques - Google Patents

Composes triaziniques

Info

Publication number: BE809369A
Authority: BE; Belgium
Prior art keywords: triazin; compounds; triazin compounds
Prior art date: 1973-01-04

Application number

BE139496A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-01-04

Filing date

1974-01-03

Publication date

1974-07-03

1974-01-03 Application filed filed Critical

1974-07-03 Publication of BE809369A publication Critical patent/BE809369A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BE139496A 1973-01-04 1974-01-03 Composes triaziniques BE809369A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB55373*[A GB1457873A (en)	1973-01-04	1973-01-04	Imidazotriazines

Publications (1)

Publication Number	Publication Date
BE809369A true BE809369A (fr)	1974-07-03

Family

ID=9706420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE139496A BE809369A (fr)	1973-01-04	1974-01-03	Composes triaziniques

Country Status (19)

Country	Link
US (1)	US3941785A (xx)
JP (1)	JPS4995994A (xx)
AT (1)	AT336029B (xx)
AU (1)	AU474078B2 (xx)
BE (1)	BE809369A (xx)
CA (1)	CA1005057A (xx)
CH (1)	CH618170A5 (xx)
DE (1)	DE2364076A1 (xx)
ES (1)	ES422001A1 (xx)
FI (1)	FI57260C (xx)
FR (1)	FR2213058B1 (xx)
GB (1)	GB1457873A (xx)
IE (1)	IE38681B1 (xx)
IL (1)	IL43872A (xx)
LU (1)	LU69099A1 (xx)
NL (1)	NL7400095A (xx)
NO (1)	NO140301C (xx)
SE (1)	SE408179B (xx)
ZA (1)	ZA739534B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK109578A (da) *	1977-03-25	1978-09-26	Allen & Hanburys Ltd	Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107309A (en) *	1977-05-23	1978-08-15	American Cyanamid Company	Substituted imidazo[1,2-d]-as-triazines
US4096257A (en) *	1977-05-23	1978-06-20	American Cyanamid Company	Substituted imidazo [1,2-d]-as-triazines
US4126444A (en) *	1977-11-22	1978-11-21	American Cynamid Company	Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof
US4308384A (en) *	1978-09-18	1981-12-29	Glaxo Group Limited	Production of triazinones
DD244681A3 (de) *	1985-12-02	1987-04-15	Zeiss Jena Veb Carl	Vorrichtung zur positionierung von enden flexibler lichtleitelemente
US6624181B1 (en) *	1997-02-28	2003-09-23	Altana Pharma Ag	Synergistic combination
EP2295436A1 (de) *	1997-11-12	2011-03-16	Bayer Schering Pharma AG	2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase V Inhibitoren
DE19827640A1 (de) *	1998-06-20	1999-12-23	Bayer Ag	7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CA2341488A1 (en)	1998-08-26	2000-03-09	Smithkline Beecham Corporation	Therapies for treating pulmonary diseases
HU229439B1 (hu) *	1999-08-21	2013-12-30	Takeda Gmbh	Roflumilast és salmeterol szinergetikus kombinációja
DE50209015D1 (de) *	2001-05-09	2007-02-01	Bayer Healthcare Ag	NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on
GB0113343D0 (en) *	2001-06-01	2001-07-25	Bayer Ag	Novel Heterocycles 2
GB0113344D0 (en) *	2001-06-01	2001-07-25	Bayer Ag	Novel heterocycles 3
DE10130167A1 (de) *	2001-06-22	2003-01-02	Bayer Ag	Imidazotriazine
DE10135815A1 (de)	2001-07-23	2003-02-06	Bayer Ag	Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10230604A1 (de) *	2002-07-08	2004-01-29	Bayer Ag	Heterocyclisch substituierte Imidazotriazine
DE10230605A1 (de) *	2002-07-08	2004-01-29	Bayer Ag	Substituierte Imidazotriazine
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
WO2004087652A2 (en) *	2003-04-01	2004-10-14	Smithkline Beecham Corporation	Imidazotriazine compounds
DE102005001989A1 (de) *	2005-01-15	2006-07-20	Bayer Healthcare Ag	Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) *	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) *	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP2258357A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en)	2005-08-26	2007-03-01	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
US20090186896A1 (en) *	2005-09-29	2009-07-23	Bayer Healthcare Ag	PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
WO2007047978A2 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20070244143A1 (en) *	2006-03-08	2007-10-18	Braincells, Inc	Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) *	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
CA2651813A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100009983A1 (en) *	2006-05-09	2010-01-14	Braincells, Inc.	5 ht receptor mediated neurogenesis
US7678808B2 (en) *	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
EP2068872A1 (en) *	2006-09-08	2009-06-17	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
CA2663347A1 (en) *	2006-09-19	2008-03-27	Braincells, Inc.	Ppar mediated modulation of neurogenesis
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
EP2167057A1 (en) *	2007-06-13	2010-03-31	Bayer HealthCare AG	Pde inhibitors for the treatment of hearing impairment
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE791025A (fr) *	1971-11-19	1973-05-07	Allen & Hanburys Ltd	Composes heterocycliques

1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/fi active
- 1973-12-18 ZA ZA739534A patent/ZA739534B/xx unknown
- 1973-12-18 NO NO4843/73A patent/NO140301C/no unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/xx unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/de not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-31 IE IE2345/73A patent/IE38681B1/xx unknown
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
1974
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-02 AT AT2374A patent/AT336029B/de not_active IP Right Cessation
- 1974-01-03 ES ES422001A patent/ES422001A1/es not_active Expired
- 1974-01-03 SE SE7400062A patent/SE408179B/xx unknown
- 1974-01-03 BE BE139496A patent/BE809369A/xx unknown
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU474078B2 (en)	1976-07-15
CA1005057A (en)	1977-02-08
GB1457873A (en)	1976-12-08
NO140301C (no)	1979-08-08
IE38681L (en)	1974-07-04
CH618170A5 (xx)	1980-07-15
FI57260C (fi)	1980-07-10
FR2213058A1 (xx)	1974-08-02
AT336029B (de)	1977-04-12
FR2213058B1 (xx)	1977-07-01
IE38681B1 (en)	1978-05-10
DE2364076A1 (de)	1974-07-18
JPS4995994A (xx)	1974-09-11
FI57260B (fi)	1980-03-31
US3941785A (en)	1976-03-02
NL7400095A (xx)	1974-07-08
LU69099A1 (xx)	1974-04-02
ATA2374A (de)	1976-08-15
ES422001A1 (es)	1976-08-01
NO140301B (no)	1979-04-30
AU6377473A (en)	1975-06-19
ZA739534B (en)	1974-11-27
SE408179B (sv)	1979-05-21
IL43872A0 (en)	1974-03-14
IL43872A (en)	1979-01-31

Publication	Publication Date	Title
BE809369A (fr)	1974-07-03	Composes triaziniques
BE816519A (fr)	1974-12-18	Composes aotes
SE388554B (sv)	1976-10-11	Svarv
BE819116A (fr)	1975-02-24	Composes polyeniques
BE822846A (fr)	1975-06-02	Composes (1-alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryliques
BE819117A (fr)	1975-02-24	Composes polyeniques
BE820848A (fr)	1975-04-09	Composes triglycidyliques
FI54178C (fi)	1978-10-10	Foerfaringssaett foer framstaellning av ett foerstyvat isolationselement
BE823401A (fr)	1975-06-16	Composes (1-alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryliques
BE812672A (fr)	1974-09-23	Composes heterocycliques
BE814467A (fr)	1974-11-04	Composes tetracycliques amino-substitues
BE823625A (fr)	1975-06-20	Composes heteroxycliques
FI53973C (fi)	1978-09-11	Foerfarande foer framstaellning av 6-amino-penicillansyra
BE819486A (fr)	1975-03-03	Composes monoazoiques hydrosolubles
BE822343R (fr)	1975-05-20	Composes imidazoliques
IT1048168B (it)	1980-11-20	Composti organostannici
BE822291A (fr)	1975-05-20	Composes de (1-alkyl-5-nitro-imidazolyl-2-alkyl) pyridyle
BE822232A (fr)	1975-05-14	Composes polycycliques
BE811006A (fr)	1974-08-14	Composes anthraquinoniques
BE818108A (fr)	1975-01-27	Phenylglycylcephalosporines substituees
FI53679C (fi)	1978-07-10	Foerfarande foer framstaellning av skivor av traematerial
FI54813B (fi)	1978-11-30	Foerfarande foer framstaellning av kortfibrer fraon termoplaster
BE817590A (fr)	1975-01-13	Composes trifluoromethyl-amino-aryl-sulfonyliques
BE813003A (fr)	1974-09-30	Composes tricycliques
BE816698A (fr)	1974-12-23	Composes phosphoreux